RRML - SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- March 2024 -
 
Comparison of Total Bilirubin ... 1
Implications of visfatin genet... 1
HBV genotypes circulation in p... 1
Characterization of antibiotic... 1
Total Errors of TSH results by... 1
Evaluation of Plasma AA/DHA+EP... 1
Expressions and clinical signi... 1
Understanding the key differen... 1
Vancomycin-resistant enterococ... 1
Recomandarea comună EFLM-COLA... 1

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 30(3)/2022 DOI:10.2478/rrlm-2022-0028
XML
TXT

Research article

SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration

Qian Guo, Wei He, Dan Nie, Wuzhi Li, Ping Zhan

Correspondence should be addressed to: Ping Zhan

Abstract:

Background: Cervical cancer is the fourth commonly occurred cancer in women around the world. However, it still lacks effective approaches to improve current prognosis of cervical cancer and prevent metastasis. Objective: We aim to discover a promising biomarker for cervical cancer prognosis by utilizing bioinformatics analysis. Methods: Gene expression was analyzed by the datasets from The Cancer Genome Atlas Program-Cervical squamous cell carcinoma and endocervical adenocarcinoma (TCGA-CESC) dataset and three independent patient cohort datasets. Biological process and pathway enrichment were performed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis. Immune infiltration was analyzed through TISIDB tool. Results: SPP1 gene was highly expressed in cervical cancer tissues. In addition, SPP1 was positively correlated to advanced CESC stages and nodal metastasis status. SPP1 co-expressed genes are mainly enriched in immunological processes. Furthermore, SPP1 expression is involved in immune infiltration level, in which several tumour infiltrating lymphocytes are correlated with SPP1. SPP1 overexpression promotes a wide spectrum of chemokines and immunoinhibiors which contribute to CESC progression. Conclusions: SPP1 is a promising biomarker and a prognostic factor of CESC. Tumour infiltrating lymphocytes are also possibly regulated by SPP1. Our study suggests that investigation on SPP1 is a new direction for CESC therapy.

Keywords: bioinformatics analysis, SPP1, tumour infiltrating lymphocytes, cervical cancer

Received: 23.1.2022
Accepted: 3.6.2022
Published: 14.6.2022

 
  PDF Download full text PDF
(4436 KB)
     
 
How to cite
Guo Q, He W, Nie D, Li W, Zhan P. SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration. Rev Romana Med Lab. 2022;30(3):281-92. DOI:10.2478/rrlm-2022-0028